u/sequence_checker

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

private plans vary by employer

Flair changed to match the content. Read the sidebar before posting next time and we are square.

Flair changed to match the content. Read the sidebar before posting next time and we are square.

Removed a chain here. The rule is one line long and it is not negotiable.

Same experience. Week 66 and it simply stopped. I know that is not useful information but it is what happened.

Germany to Germany: 6 days with SGN and 30 days with WWB. Same route, different carriers, variance is real.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

This is the "correlation is mechanism" thing again. You changed three variables at once.

Tracking number removed. It identifies both ends of a shipment.

Yeah, data logger is the only acceptable proof.

Disagree on that part. 98.1% and 97.6% on the same vial is normal.

regulatory status changed in 5 countries, check yours

cross-border pricing arbitrage is private plan but risky

Sceptical. If this were true we would see it reflected in the data and we do not.

The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does cagrilintide.

This is the "correlation is mechanism" thing again. You changed three variables at once.

Are you on a pen or research vial? The formulation changes the profile.

Maintenance for 12 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

Removed a chain here. The rule is one line long and it is not negotiable.

This is the "correlation is mechanism" thing again. You changed three variables at once.